Bill Text: FL S0104 | 2019 | Regular Session | Comm Sub
Bill Title: Prescription Drug Donation Repository Program
Spectrum:
Status: (Failed) 2019-05-03 - Died in Appropriations [S0104 Detail]
Download: Florida-2019-S0104-Comm_Sub.html
Florida Senate - 2019 CS for SB 104
By the Committee on Health Policy; and Senator Book
588-02164-19 2019104c1
1 A bill to be entitled
2 An act relating to the Prescription Drug Donation
3 Repository Program; creating s. 465.1902, F.S.;
4 providing a short title; defining terms; creating the
5 Prescription Drug Donation Repository Program within
6 the Department of Health; specifying the purpose of
7 the program; authorizing the department to contract
8 with a third-party vendor to administer the program;
9 specifying entities that are eligible donors;
10 authorizing certain local repositories to accept a
11 donation from specified persons under certain
12 conditions; prohibiting a centralized repository or a
13 local repository from accepting donations from
14 unauthorized donors; providing criteria and procedures
15 for eligible donations; prohibiting donations to
16 specific patients; providing that certain prescription
17 drugs eligible for return to stock must be credited to
18 Medicaid and may not be donated under the program;
19 prohibiting the donation of certain drugs pursuant to
20 federal restrictions; clarifying that a repository is
21 not required to accept donations of prescription drugs
22 or supplies; providing inspection, inventory, and
23 storage requirements for centralized and local
24 repositories; requiring inspection of donated
25 prescription drugs and supplies by a licensed
26 pharmacist; requiring a local repository to notify the
27 centralized repository within a specified timeframe
28 after receiving a donation of prescription drugs or
29 supplies; authorizing the centralized repository to
30 redistribute prescription drugs or supplies;
31 authorizing a local repository to transfer
32 prescription drugs or supplies to another local
33 repository with authorization from the centralized
34 repository; requiring a local repository to notify the
35 department of its intent to participate in the
36 program; providing notification requirements;
37 providing a procedure for a local repository to
38 withdraw from participation in the program; requiring
39 the department to adopt rules regarding the
40 disposition of prescription drugs and supplies of a
41 withdrawing local repository; specifying conditions
42 for dispensing donated prescription drugs and supplies
43 to eligible patients; providing intake collection form
44 requirements; requiring a local repository to issue an
45 eligible patient who completes an intake collection
46 form a program identification card; prohibiting the
47 sale of donated prescription drugs and supplies under
48 the program; authorizing a repository to charge the
49 patient a nominal handling fee for the preparation and
50 dispensing of prescription drugs or supplies under the
51 program; requiring repositories to establish a
52 protocol for notifying recipients of a prescription
53 drug recall; providing for destruction of donated
54 prescription drugs under certain circumstances;
55 providing recordkeeping requirements; requiring the
56 centralized repository to submit an annual report to
57 the department; requiring the department or contractor
58 to establish, maintain, and publish a registry of
59 participating local repositories and available donated
60 prescription drugs and supplies; requiring the
61 department to publish certain information and forms on
62 its website; providing immunity from civil and
63 criminal liability and from professional disciplinary
64 action for participants under certain circumstances;
65 providing immunity to pharmaceutical manufacturers,
66 under certain circumstances, from any claim or injury
67 arising from the donation of any prescription drug or
68 supply under the program; requiring dispensers to
69 provide certain notice to patients; authorizing the
70 department to establish a direct-support organization
71 to provide assistance, funding, and promotional
72 support for program activities; providing
73 organizational requirements for a direct-support
74 organization; specifying direct-support organization
75 purposes and objectives; prohibiting the direct
76 support organization from lobbying; specifying that
77 the direct-support organization is not a lobbying
78 firm; prohibiting the direct-support organization from
79 possessing prescription drugs on behalf of the
80 program; providing limitations on expenditures of such
81 direct-support organizations; specifying that the
82 direct-support organization must operate under
83 contract with the department; specifying required
84 contract terms; providing for the direct-support
85 organization board of directors; specifying the
86 board’s membership requirements; specifying
87 requirements and requiring the department to adopt
88 rules relating to a direct-support organization’s use
89 of department property; specifying requirements for
90 the deposit and use of funds by the direct-support
91 organization; providing for annual audits of a direct
92 support organization; providing for future legislative
93 review and repeal of provisions relating to the
94 direct-support organization; requiring the department
95 to adopt rules; amending s. 252.36, F.S.; authorizing
96 the Governor to waive program patient eligibility
97 requirements during a declared state of emergency;
98 providing an effective date.
99
100 Be It Enacted by the Legislature of the State of Florida:
101
102 Section 1. Section 465.1902, Florida Statutes, is created
103 to read:
104 465.1902 Prescription Drug Donation Repository Program.—
105 (1) SHORT TITLE.—This section may be cited as the
106 “Prescription Drug Donation Repository Program Act.”
107 (2) DEFINITIONS.—As used in this section, the term:
108 (a) “Centralized repository” means a distributor permitted
109 under chapter 499 who is approved by the department or the
110 contractor to accept, inspect, inventory, and distribute donated
111 drugs and supplies under this section.
112 (b) “Closed drug delivery system” means a system in which
113 the actual control of the unit-dose medication package is
114 maintained by the facility, rather than by the individual
115 patient.
116 (c) “Contractor” means the third-party vendor approved by
117 the department to implement and administer the program as
118 authorized in subsection (4).
119 (d) “Controlled substance” means any substance listed under
120 Schedule II, Schedule III, Schedule IV, or Schedule V of s.
121 893.03.
122 (e) “Direct-support organization” means the entity created
123 under subsection (15).
124 (f) “Dispenser” means a health care practitioner who,
125 within the scope of his or her practice act, is authorized to
126 dispense medicinal drugs and who does so under this act.
127 (g) “Donor” means an entity specified in subsection (5).
128 (h) “Eligible patient” means a Florida resident who is
129 indigent, uninsured, or underinsured and who has a valid
130 prescription for a prescription drug or supply that may be
131 dispensed under the program.
132 (i) “Free clinic” means a clinic that delivers only medical
133 diagnostic services or nonsurgical medical treatment free of
134 charge to low-income recipients.
135 (j) “Health care practitioner” or “practitioner” means a
136 practitioner licensed under this chapter, chapter 458, chapter
137 459, chapter 461, chapter 463, chapter 464, or chapter 466.
138 (k) “Indigent” means an individual whose family income for
139 the 12 months preceding the determination of income is below 200
140 percent of the federal poverty level as defined by the most
141 recently revised poverty income guidelines published by the
142 United States Department of Health and Human Services.
143 (l) “Local repository” means a health care practitioner’s
144 office, a pharmacy, a hospital with a closed drug delivery
145 system, a nursing home facility with a closed drug delivery
146 system, or a free clinic or nonprofit health clinic that is
147 licensed or permitted to dispense medicinal drugs in the state.
148 (m) “Nonprofit health clinic” means a nonprofit legal
149 entity that provides medical care to patients who are indigent,
150 uninsured, or underinsured. The term includes, but is not
151 limited to, a federally qualified health center as defined in 42
152 U.S.C. s. 1396d(l)(2)(B) and a rural health clinic as defined in
153 42 U.S.C. s. 1396d(l)(1).
154 (n) “Nursing home facility” has the same meaning as in s.
155 400.021.
156 (o) “Prescriber” means a health care practitioner who,
157 within the scope of his or her practice act, is authorized to
158 prescribe medicinal drugs.
159 (p) “Prescription drug” has the same meaning as the term
160 “medicinal drugs” or “drugs,” as those terms are defined in s.
161 465.003(8), but does not include controlled substances or cancer
162 drugs donated under s. 499.029.
163 (q) “Program” means the Prescription Drug Donation
164 Repository Program created by this section.
165 (r) “Supplies” means any supply used in the administration
166 of a prescription drug.
167 (s) “Tamper-evident packaging” means a package that has one
168 or more indicators or barriers to entry which, if breached or
169 missing, can reasonably be expected to provide visible evidence
170 to consumers that tampering has occurred.
171 (t) “Underinsured” means a person who has third-party
172 insurance or is eligible to receive prescription drugs or
173 supplies through the Medicaid program or any other prescription
174 drug program funded in whole or in part by the Federal
175 Government, but who has exhausted these benefits or does not
176 have prescription drug coverage for the drug prescribed.
177 (u) “Uninsured” means a person who has no third-party
178 insurance and is not eligible to receive prescription drugs or
179 supplies through the Medicaid program or any other prescription
180 drug program funded in whole or in part by the Federal
181 Government.
182 (3) PRESCRIPTION DRUG DONATION REPOSITORY PROGRAM;
183 CREATION; PURPOSE.—The Prescription Drug Donation Repository
184 Program is created within the department for the purpose of
185 authorizing and facilitating the donation of prescription drugs
186 and supplies to eligible patients.
187 (4) PROGRAM IMPLEMENTATION; ADMINISTRATION.—The department
188 may contract with a third-party vendor to administer the
189 program.
190 (5) DONOR ELIGIBILITY.—
191 (a) The centralized repository or a local repository may
192 accept a donation of a prescription drug or supply from:
193 1. Nursing home facilities with closed drug delivery
194 systems.
195 2. Hospices that have maintained control of a patient’s
196 prescription drugs.
197 3. Hospitals with closed drug delivery systems.
198 4. Pharmacies.
199 5. Drug manufacturers or wholesale distributors.
200 6. Medical device manufacturers or suppliers.
201 7. Prescribers who receive prescription drugs or supplies
202 directly from a drug manufacturer, wholesale distributor, or
203 pharmacy.
204 (b) In addition to the donors specified in paragraph (a), a
205 local repository that qualifies as a free clinic or nonprofit
206 health clinic may accept a donation from a patient or a
207 patient’s legal representative or next of kin if the following
208 requirements are met:
209 1. An affidavit, in a format approved by the department,
210 signed by the donor must accompany the donation, identify the
211 prescribing health care practitioner, and attest to the
212 authenticity of the prescription drug or medical supply being
213 donated;
214 2. The prescription drug or medical supply being donated is
215 in its original tamper-evident packaging, in accordance with
216 subparagraph (6)(b)1., and does not have any physical signs of
217 tampering, misbranding, deterioration, compromised integrity, or
218 adulteration;
219 3. Any drug being donated has an expiration date that is
220 more than 3 months after the date of the donation; and
221 4. A licensed pharmacist inspects the prescription drug or
222 medical supply and can attest to the authenticity of the donated
223 prescription drug or medical supply and that it meets the
224 requirements of this paragraph.
225
226 Prescription drugs and supplies accepted under this paragraph
227 are exempt from subparagraph (6)(b)3. but are subject to all
228 other applicable requirements of subsections (6) and (7).
229 (c) Donations of prescription drugs or supplies may not be
230 accepted by the centralized repository or a local repository
231 from any donor not authorized under this subsection.
232 (6) PRESCRIPTION DRUGS AND SUPPLIES ELIGIBLE FOR DONATION;
233 DONATION REQUIREMENTS; PROHIBITED DONATIONS.—
234 (a) Only prescription drugs and supplies that have been
235 approved for medical use in the United States and that meet the
236 criteria for donation established by this section may be
237 accepted for donation under the program. Donations must be made
238 on the premises of the centralized repository or a local
239 repository to a person designated by the repository. A drop box
240 may not be used to accept donations.
241 (b) The centralized repository or a local repository may
242 accept a prescription drug only if:
243 1. The drug is in its original sealed and tamper-evident
244 packaging. Single-unit-dose drugs may be accepted if the single
245 unit-dose packaging is unopened.
246 2. The drug requires storage at normal room temperature per
247 the manufacturer or the United States Pharmacopeia.
248 3. The drug has been stored according to manufacturer or
249 United States Pharmacopeia storage requirements.
250 4. The drug does not have any physical signs of tampering
251 or adulteration and there is no reason to believe that the drug
252 is adulterated.
253 5. The packaging does not have any physical signs of
254 tampering, misbranding, deterioration, compromised integrity, or
255 adulteration.
256 6. The packaging indicates the lot number and expiration
257 date of the drug. If the lot number is not retrievable, all
258 specified medications must be destroyed in the event of a
259 recall.
260 7. The drug has an expiration date that is more than 3
261 months after the date that the drug was donated.
262 (c) The centralized repository or a local repository may
263 accept supplies only if they are in their original, unopened,
264 sealed packaging and have not been tampered with or misbranded.
265 (d) Prescription drugs or supplies may not be donated to a
266 specific patient.
267 (e) Prescription drugs billed to and paid for by Medicaid
268 in long-term care facilities which are eligible for return to
269 stock under federal Medicaid regulations must be credited to
270 Medicaid and may not be donated under the program.
271 (f) Prescription drugs with an approved Federal Food and
272 Drug Administration Risk Evaluation and Mitigation Strategy that
273 includes Elements to Assure Safe Use are not eligible for
274 donation under the program.
275 (g) This section does not require the centralized
276 repository or a local repository to accept a donation of
277 prescription drugs or supplies.
278 (7) INSPECTION AND STORAGE.—
279 (a) A licensed pharmacist employed by or under contract
280 with the centralized repository or a local repository shall
281 inspect donated prescription drugs and supplies to determine
282 whether they meet the requirements of subsections (5) and (6).
283 (b) The inspecting pharmacist must sign an inspection
284 record on a form prescribed by the department by rule which
285 verifies that the prescription drugs and supplies meet the
286 criteria of subsections (5) and (6) and must attach the record
287 to the inventory required by paragraph (d). A local repository
288 that receives drugs and supplies from the centralized repository
289 is not required to reinspect them.
290 (c) The centralized repository and local repositories shall
291 store donated prescription drugs and supplies in a secure
292 storage area under the environmental conditions specified by the
293 manufacturer or the United States Pharmacopeia for the
294 respective prescription drugs or supplies. Donated prescription
295 drugs and supplies may not be stored with other inventory. A
296 local repository shall quarantine donated prescription drugs or
297 supplies until they are inspected and approved for dispensing
298 under this section.
299 (d) The centralized repository and local repositories shall
300 maintain an inventory of all donated prescription drugs or
301 supplies. Such inventory at local repositories shall be recorded
302 on a form prescribed by the department by rule.
303 (e) A local repository shall notify the centralized
304 repository within 5 days after receipt of any donation of
305 prescription drugs or supplies to the program. The notification
306 must be on a form prescribed by the department by rule.
307 (f) The centralized repository may redistribute
308 prescription drugs and supplies by transferring them to or from
309 the centralized repository and a local repository, as needed. A
310 local repository that receives donated prescription drugs or
311 supplies may, with authorization from the centralized
312 repository, distribute the prescription drugs or supplies to
313 another local repository.
314 (8) PROGRAM PARTICIPATION.—
315 (a) A practitioner, pharmacy, facility, or clinic must
316 notify the department of its intent to participate in the
317 program as a local repository before accepting or dispensing any
318 prescription drugs or supplies pursuant to this section. The
319 notification must be made on a form prescribed by the department
320 by rule and must, at a minimum, include:
321 1. The name, street address, website, and telephone number
322 of the intended local repository and any license or registration
323 number issued by the state to the intended local repository,
324 including the name of the issuing agency.
325 2. The name and telephone number of the pharmacist employed
326 by or under contract with the intended local repository who is
327 responsible for the inspection of donated prescription drugs and
328 supplies.
329 3. A signed and dated statement by the responsible
330 pharmacist affirming that the intended local repository meets
331 the eligibility requirements of this section.
332 (b) A local repository may withdraw from participation in
333 the program at any time by providing written notice to the
334 department or contractor, as appropriate, on a form prescribed
335 by the department by rule. The department shall adopt rules
336 addressing the disposition of prescription drugs and supplies in
337 the possession of the withdrawing local repository.
338 (9) DISPENSING REQUIREMENTS; PROHIBITIONS.—
339 (a) Each eligible patient without a program identification
340 card must submit an intake collection form to a local repository
341 before receiving prescription drugs or supplies under the
342 program. The department shall prescribe a form by rule, which
343 must include at least all of the following:
344 1. The name, street address, and telephone number of the
345 eligible patient.
346 2. The basis for eligibility, which must specify that the
347 patient is indigent, uninsured, or underinsured.
348 3. A statement signed and dated by the eligible patient
349 affirming that he or she meets the eligibility requirements of
350 this section.
351 (b) Upon receipt of a completed and signed intake
352 collection form, the local repository shall issue him or her a
353 program identification card, which is valid for 1 year after its
354 date of issuance. The card must be in a form prescribed by the
355 department by rule.
356 (c) The local repository shall send a summary of each
357 intake collection form to the centralized pharmacy within 5 days
358 after receiving it.
359 (d) A dispenser may dispense donated prescription drugs or
360 supplies only to an eligible patient who has a program
361 identification card or who has submitted a completed intake
362 collection form.
363 (e) A dispenser shall inspect the donated prescription
364 drugs or supplies before dispensing them.
365 (f) A dispenser may provide dispensing and consulting
366 services to an eligible patient.
367 (g) Donated prescription drugs and supplies may not be sold
368 or resold under the program.
369 (h) A dispenser of donated prescription drugs or supplies
370 may not submit a claim or otherwise seek reimbursement from any
371 public or private third-party payor for donated prescription
372 drugs or supplies dispensed under this program. However, a
373 repository may charge the patient a nominal handling fee,
374 established by department rule, for the preparation and
375 dispensing of prescription drugs or supplies under the program.
376 (10) RECALLED PRESCRIPTION DRUGS AND SUPPLIES.—
377 (a) The centralized repository and each local repository
378 shall establish and follow a protocol for notifying recipients
379 in the event of a prescription drug recall.
380 (b) Local repositories shall destroy all recalled or
381 expired prescription drugs and all prescription drugs that are
382 not suitable for dispensing in the repository. Local
383 repositories must complete a destruction information form for
384 all such drugs, in accordance with department rule.
385 (11) RECORDKEEPING.—
386 (a) Local repositories shall maintain records of
387 prescription drugs and supplies that are accepted, donated,
388 dispensed, distributed, or destroyed under the program.
389 (b) All required records must be maintained in accordance
390 with any applicable practice act. Local repositories shall
391 submit these records quarterly to the centralized repository for
392 data collection, and the centralized repository shall submit
393 these records and the collected data in annual reports to the
394 department.
395 (12) REGISTRIES; PUBLICATION OF FORMS.—
396 (a) The department or contractor shall establish and
397 maintain registries of all local repositories and of
398 prescription drugs and supplies available under the program. The
399 registry of local repositories must include each repository’s
400 name, address, website, and telephone number. The registry of
401 available prescription drugs and supplies must include the name,
402 strength, available quantity, and expiration date of the
403 prescription drug or supplies and the name and contact
404 information of each repository where such drug or supplies are
405 available. The department shall publish the registries on its
406 website.
407 (b) The department shall publish all forms required by this
408 section on its website.
409 (13) IMMUNITY FROM LIABILITY, DISCIPLINARY ACTION.—
410 (a) Any donor of prescription drugs or supplies and any
411 participant in the program who exercises reasonable care in
412 donating, accepting, distributing, or dispensing prescription
413 drugs or supplies under the program is immune from civil or
414 criminal liability and from professional disciplinary action by
415 the state for any injury, death, or loss to person or property
416 relating to such activities.
417 (b) A pharmaceutical manufacturer who exercises reasonable
418 care is not liable for any claim or injury arising from the
419 donation of any prescription drug or supply under this section,
420 including, but not limited to, liability for failure to transfer
421 or communicate product or consumer information regarding the
422 donated prescription drug, including its expiration date.
423 (14) NOTICE TO PATIENTS.—Before dispensing a donated
424 prescription drug under the program, the dispenser must provide
425 written notification to the eligible patient or his or her legal
426 representative, receipt of which must be acknowledged in
427 writing, of all of the following information:
428 (a) The prescription drug was donated to the program.
429 (b) The donors and participants in the program are immune
430 from civil or criminal liability or disciplinary action.
431 (c) The eligible patient is not required to pay for the
432 prescription drug, but may be required to pay a nominal handling
433 fee, which may not exceed the amount established by department
434 rule.
435 (15) DIRECT-SUPPORT ORGANIZATION.—The department may
436 establish a direct-support organization to provide assistance,
437 funding, and promotional support for the activities authorized
438 under the act.
439 (a) Entity organization.—The direct-support organization
440 must operate in accordance with s. 20.058 and is:
441 1. A Florida corporation not for profit incorporated under
442 chapter 617, exempted from filing fees, and approved by the
443 Department of State.
444 2. Organized and operated to conduct programs and
445 activities; raise funds and request and receive grants, gifts,
446 and bequests of moneys; acquire, receive, hold, and invest, in
447 its own name, securities, funds, objects of value, or other
448 property, either real or personal; and make expenditures or
449 provide funding to or for the direct or indirect benefit of the
450 program.
451 (b) Purposes and objectives.—The purposes and objectives of
452 the direct-support organization must be consistent with the
453 goals of the department, in the best interest of the state, and
454 in accordance with the adopted goals and the mission of the
455 department.
456 (c) Prohibition against lobbying.—The direct-support
457 organization is not considered a lobbying firm, as that term is
458 defined in s. 11.045(1). All expenditures of the direct-support
459 organization must be directly related to program administration
460 within the requirements of this section. Funds of the direct
461 support organization may not be used for the purpose of
462 lobbying, as that term is defined in s. 11.045(1).
463 (d) Possession of prescription drugs.—The direct-support
464 organization may not possess any prescription drugs on behalf of
465 the program.
466 (e) Contract.—The direct-support organization shall operate
467 under a written contract with the department.
468 1. The contract must require the direct-support
469 organization to submit to the department, annually by August 1,
470 the following information, which must be posted on the websites
471 of the direct-support organization and the department:
472 a. The articles of incorporation and bylaws of the direct
473 support organization, as approved by the department.
474 b. A proposed annual budget for the approval of the
475 department.
476 c. The code of ethics of the direct-support organization.
477 d. The statutory authority or executive order that created
478 the direct-support organization.
479 e. A brief description of the direct-support organization’s
480 mission and any results obtained by the direct-support
481 organization.
482 f. A brief description of the direct-support organization’s
483 annual plan for each of the next 3 fiscal years.
484 g. A copy of the direct-support organization’s most recent
485 federal Internal Revenue Service Return Organization Exempt from
486 Income Tax form (Form 990).
487 h. Certification by the department that the direct-support
488 organization is complying with the terms of the contract and
489 operating in a manner consistent with the goals and purposes of
490 the department and the best interest of the program and the
491 state. Such certification must be made annually and reported in
492 the official minutes of a meeting of the board of directors of
493 the direct-support organization.
494 2. The contract must, at a minimum, provide for:
495 a. The reversion without penalty to the department, or to
496 the state if the department ceases to exist, of all moneys and
497 property held in trust by the direct-support organization for
498 the benefit of the program if the direct-support organization
499 ceases to exist or if the contract is terminated.
500 b. A disclosure of material provisions of the contract and
501 the distinction between the department and the direct-support
502 organization to appear on all promotional and fundraising
503 publications.
504 c. A list of prescription drugs solicited by the direct
505 support organization for distribution to the centralized
506 repository or a local repository.
507 (f) Board of directors.—The State Surgeon General shall
508 appoint the board of directors, which must consist of at least 5
509 members, but not more than 15 members, who serve at his or her
510 pleasure. The board must elect a chair from among its members.
511 Board members must serve without compensation but may be
512 entitled to reimbursement of travel and per diem expenses in
513 accordance with s. 112.061, if funds are available for this
514 purpose.
515 (g) Use of property.—The department may allow, without
516 charge, appropriate use of fixed property, facilities, and
517 personnel services of the department by the direct-support
518 organization for purposes related to the program. For purposes
519 of this paragraph, the term “personnel services” includes full
520 time or part-time personnel, as well as payroll processing
521 services.
522 1. The department may prescribe any condition with which
523 the direct-support organization must comply in order to use
524 fixed property or facilities of the department.
525 2. The department may not allow the use of any fixed
526 property or facilities of the department by the direct-support
527 organization if the organization does not provide equal
528 membership and employment opportunities to all persons
529 regardless of race, color, religion, sex, age, or national
530 origin.
531 3. The department shall adopt rules prescribing the
532 procedures by which the direct-support organization is governed
533 and any conditions with which a direct-support organization must
534 comply to use property or facilities of the department.
535 (h) Deposit of funds.—Any moneys of the direct-support
536 organization may be held in a separate depository account in the
537 name of the organization and subject to the provisions of the
538 organization’s contract with the department.
539 (i) Use of funds.—Funds designated for the direct-support
540 organization must be used for the enhancement of program
541 projects and in a manner consistent with that purpose. Any
542 administrative costs of running and promoting the purposes of
543 the organization or program must be paid by private funds.
544 (j) Audit.—The direct-support organization shall provide
545 for an annual financial audit in accordance with s. 215.981.
546 (k) Repeal.—This subsection is repealed on October 1, 2024,
547 unless reviewed and saved from repeal by the Legislature.
548 (16) RULEMAKING.—The department shall adopt rules necessary
549 to administer this section. When applicable, the rules may
550 provide for the use of electronic forms, recordkeeping, and
551 meeting by teleconference.
552 Section 2. Paragraph (o) is added to subsection (5) of
553 section 252.36, Florida Statutes, to read:
554 252.36 Emergency management powers of the Governor.—
555 (5) In addition to any other powers conferred upon the
556 Governor by law, she or he may:
557 (o) Waive the patient eligibility requirements of s.
558 465.1902.
559 Section 3. This act shall take effect July 1, 2019.
